Mark Barnett Funds Downgraded on Small-Cap Concerns

Morningstar analysts have downgraded the Invesco Income and Invesco High Income funds to "Neutral" amid concerns about their small-cap exposure and liquidity 

Holly Black 7 November, 2019 | 9:46AM
Facebook Twitter LinkedIn

Mark Barnett

The Invesco High Income and Income funds, run by Neil Woodford protégé Mark Barnett, have been downgraded by Morningstar analysts to a Neutral rating.

Concerns about the fund’s high exposure to smaller and illiquid companies have sparked the change, as well “an increasing number of stock-selection issues” which have caused analysts to have a lower level of conviction in the fund.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
4d pharma PLC61.00 GBP0.00
e-Therapeutics PLC43.05 GBP0.00
Invesco UK Eq High Inc UK Z Acc282.95 GBP0.65Rating
Invesco UK Equity Inc UK Z Acc286.22 GBP0.53Rating
Provident Financial PLC350.00 GBP0.00

About Author

Holly Black  is Senior Editor,